PSYCHEMEDICS CORP Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenues
Cost of revenues
Gross profit
Operating Expenses:
General and administrative
Marketing and selling
Research and development
Total Operating Expenses
Operating Loss
Other Expense:
Gain on forgiveness of PPP Loan
Settlements
Other expense
Total Other Expense
Net loss before provision for (benefit from) income taxes
Provision for (benefit from) income taxes
Net loss and comprehensive loss
Foreign currency translation, net of taxes
Total Comprehensive Loss
Basic and diluted net loss per share (in dollars per share)
Dividends declared, per share (in dollars per share)
Weighted average common shares outstanding
Basic (in shares)
Diluted (in shares)

Comments